Catalyst Funds Management Pty Ltd Invests $1.08 Million in Amrize Ltd $AMRZ

Catalyst Funds Management Pty Ltd acquired a new position in shares of Amrize Ltd (NYSE:AMRZFree Report) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 20,000 shares of the company’s stock, valued at approximately $1,082,000.

A number of other large investors also recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in shares of Amrize by 5.6% during the 4th quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company’s stock worth $1,722,500,000 after buying an additional 1,676,843 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Amrize by 48.8% during the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock worth $561,018,000 after buying an additional 3,809,133 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Amrize by 1.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,674,921 shares of the company’s stock worth $532,076,000 after buying an additional 156,903 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Amrize by 4.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,518,018 shares of the company’s stock worth $459,242,000 after buying an additional 420,728 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its stake in shares of Amrize by 4.9% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 4,601,319 shares of the company’s stock worth $255,051,000 after buying an additional 214,393 shares during the last quarter.

Insiders Place Their Bets

In related news, CEO Jan Philipp Jenisch acquired 3,000 shares of the business’s stock in a transaction on Tuesday, May 19th. The stock was purchased at an average cost of $49.96 per share, for a total transaction of $149,880.00. Following the completion of the transaction, the chief executive officer directly owned 515,000 shares of the company’s stock, valued at approximately $25,729,400. The trade was a 0.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mario Gross acquired 1,200 shares of the business’s stock in a transaction on Wednesday, May 20th. The shares were bought at an average price of $48.63 per share, with a total value of $58,356.00. Following the completion of the transaction, the insider directly owned 34,747 shares of the company’s stock, valued at approximately $1,689,746.61. The trade was a 3.58% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased 129,554 shares of company stock worth $7,051,569 over the last three months. Insiders own 0.54% of the company’s stock.

Analyst Upgrades and Downgrades

AMRZ has been the subject of a number of recent research reports. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective for the company in a research note on Friday, May 1st. Royal Bank Of Canada reduced their price objective on shares of Amrize from $61.00 to $60.00 and set a “sector perform” rating for the company in a research note on Friday, May 1st. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Amrize in a research note on Monday, February 23rd. Oppenheimer set a $68.00 price objective on shares of Amrize in a research note on Friday, May 1st. Finally, Wells Fargo & Company cut their target price on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, April 15th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $64.86.

View Our Latest Stock Analysis on Amrize

Amrize Trading Down 1.0%

Shares of NYSE:AMRZ opened at $49.96 on Friday. Amrize Ltd has a 52-week low of $44.12 and a 52-week high of $65.94. The company has a market capitalization of $27.63 billion and a P/E ratio of 23.91. The company has a 50-day simple moving average of $54.78 and a 200 day simple moving average of $55.08. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40.

Amrize (NYSE:AMRZGet Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The company had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.Amrize’s quarterly revenue was up 4.7% compared to the same quarter last year. Sell-side analysts forecast that Amrize Ltd will post 2.76 earnings per share for the current year.

Amrize Cuts Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is 21.05%.

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.